Table 5.
Barriers | % |
---|---|
Patient-Specific* | |
Lack of time to participate in clinical trials | 63% |
Lack of awareness of the trial | 50% |
Lack of willingness to be randomized | 44% |
Lack of understanding about clinical trials (in general) | 44% |
Lack of trust in clinical research/research staff | 31% |
Preference toward standard therapy | 31% |
Anxiety/Concern around the informed consent process | 25% |
Motivation for treatment is variable+ | 6% |
Trial-Specific* | |
Restrictive/Extensive eligibility criteria | 75% |
Study protocol complexity (not including eligibility criteria) | 69% |
Competition from nearby clinical trials | 44% |
Loss of staff motivation in recruitment | 38% |
Lack of coordination at trial start-up | 19% |
* Respondents may have multiple answers; + Specified by respondent